Rift Valley Fever Phlebo Virus Nucleocapsid Protein Polyclonal Antibody
Sizes: 50µl, 100µl
Catalogue Numbers: NCP0154P-50, NCP0154P-100
Swiss-Prot: DQ380154.1
Host: Rabbit
Reactivity: RVFV-NP
Applications: WB, ELISA
All Applications: WB: 1:500~1:2000
ELISA: 1:5000~10000
Background: Rift Valley fever (RVF) is a mosquito-borne viral zoonosis that was first discovered in Kenya in 1930 and is now endemic throughout multiple African countries and the Arabian Peninsula. RVF virus primarily infects domestic livestock (sheep, goats, cattle) causing high rates of neonatal mortality and abortion, with human infection resulting in a wide variety of clinical outcomes, ranging from self-limiting febrile illness to life-threatening haemorrhagic diatheses, and miscarriage in pregnant women. Since its discovery, RVF has caused many outbreaks in Africa and the Arabian Peninsula with major impacts on human and animal health. However, options for the control of RVF outbreaks are limited by the lack of licensed human vaccines or therapeutics.
Product: Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2.
Purification and Purity: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
Storage and Stability: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity: Rift Valley fever phlebovirus Nucleocapsid Protein polyclonal antibody detects endogenous levels of RVFV-NP protein.
Note: For research use only, not for use in diagnostic procedure.
Immunogen: Recombinant protein of RVFV-NP.
Conjugate: Unconjugated
Modification: Unmodified